• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

负载硝苯地平的聚乳酸/壳聚糖纳米颗粒:表征结果及动物实验研究

Polylactic Acid/Chitosan Nanoparticles Loading Nifedipine: Characterization Findings and Investigation in Animal.

作者信息

Chinh Nguyen Thuy, Trang Nguyen Thi Thu, Mai Tran Thi, Thanh Dinh Thi Mai, Trung Tran Huu, Trung Trinh Hoang, Quan Le Van, Hoa Nguyen Thi, Mao Can Van, Nghia Nguyen Trong, Hai Nguyen Thanh, Anh Tran Hong, Hung Tran Viet, Choy Jin-Ho, Loi Nguyen Van, Rajesh Baskaran, Hoang Thai

机构信息

Institute for Tropical Technology, Vietnam Academy of Science and Technology, 18, Hoang Quoc Viet, Cau Giay, Ha Noi, 100000, Vietnam.

Department of Physiology, Vietnam Military Medical University, 60 Phung Hung, Ha Dong, Ha Noi, 100000, Vietnam.

出版信息

J Nanosci Nanotechnol. 2018 Apr 1;18(4):2294-2303. doi: 10.1166/jnn.2018.14537.

DOI:10.1166/jnn.2018.14537
PMID:29442895
Abstract

This paper presents the results of zeta potential, water contact angle, atomic force microscopy image, in vitro solubility, and content of heavy metals in polylactic acid (PLA)/chitosan (CS) nanoparticles loading nifedipine. In addition, the In Vivo test of the PLA/CS nanoparticles loading nifedipine in the mice is also one of highlights of this work. The Zeta potential result shows that the charged surface of the PLA/CS nanoparticles loading nifedipine is neutral, negative or complex depending on nifedipine content. Nifedipine plays a role in increase of hydrophobic property, swelling degree and regular surface as well as decrease of surface rough of the nanoparticles. The PLA/CS/nifedipine nanoparticles are dissolved in the solutions with pH 6.8, pH 4.5 and pH 1.2. The In Vivo test of PLA/CS nanoparticles loading nifedipine on mice was evaluated by the change in diastolic pressure, systolic pressure, arterial pressure and heart rate. The obtained results confirm that the PLA/CS nanoparticles loading nifedipine is suitable to apply in the treatment of hypertension patients lately.

摘要

本文介绍了载有硝苯地平的聚乳酸(PLA)/壳聚糖(CS)纳米颗粒的zeta电位、水接触角、原子力显微镜图像、体外溶解度和重金属含量的结果。此外,载有硝苯地平的PLA/CS纳米颗粒在小鼠体内的试验也是这项工作的亮点之一。zeta电位结果表明,载有硝苯地平的PLA/CS纳米颗粒的带电表面根据硝苯地平含量呈中性、负性或复合性。硝苯地平在增加纳米颗粒的疏水性、溶胀度和表面规整性以及降低表面粗糙度方面发挥作用。PLA/CS/硝苯地平纳米颗粒可溶解于pH 6.8、pH 4.5和pH 1.2的溶液中。通过舒张压、收缩压、动脉压和心率的变化评估了载有硝苯地平的PLA/CS纳米颗粒对小鼠的体内试验。所得结果证实,载有硝苯地平的PLA/CS纳米颗粒适用于近期高血压患者的治疗。

相似文献

1
Polylactic Acid/Chitosan Nanoparticles Loading Nifedipine: Characterization Findings and Investigation in Animal.负载硝苯地平的聚乳酸/壳聚糖纳米颗粒:表征结果及动物实验研究
J Nanosci Nanotechnol. 2018 Apr 1;18(4):2294-2303. doi: 10.1166/jnn.2018.14537.
2
Preparation, characterization and transfection efficiency of cationic PEGylated PLA nanoparticles as gene delivery systems.阳离子聚乙二醇化聚乳酸纳米粒作为基因递送系统的制备、表征及转染效率
J Biotechnol. 2007 Jun 15;130(2):107-13. doi: 10.1016/j.jbiotec.2007.02.007. Epub 2007 Feb 17.
3
Pharmacokinetics of a novel nifedipine and pH-sensitive N-succinyl chitosan/alginate hydrogel bead in rabbits.新型硝苯地平及 pH 敏感型 N-琥珀酰壳聚糖/海藻酸钠水凝胶珠在兔体内的药代动力学。
Drug Dev Ind Pharm. 2010 Dec;36(12):1463-8. doi: 10.3109/03639045.2010.488644. Epub 2010 Aug 12.
4
Chitosan/PLA nanoparticles as a novel carrier for the delivery of anthraquinone: synthesis, characterization and in vitro cytotoxicity evaluation.壳聚糖/PLA 纳米粒作为蒽醌类药物的新型载体:合成、表征及体外细胞毒性评价。
Colloids Surf B Biointerfaces. 2013 Jan 1;101:126-34. doi: 10.1016/j.colsurfb.2012.06.019. Epub 2012 Jun 28.
5
Development of biobased multilayer films with improved compatibility between polylactic acid-chitosan as a function of transition coating of SiOx.开发具有改善的聚乳酸-壳聚糖之间相容性的生物基多层膜,作为 SiOx 过渡涂层的功能。
Int J Biol Macromol. 2020 Dec 15;165(Pt A):1258-1263. doi: 10.1016/j.ijbiomac.2020.10.001. Epub 2020 Oct 8.
6
The antihypertensive effect of orally administered nifedipine-loaded nanoparticles in spontaneously hypertensive rats.口服硝苯地平纳米粒对自发性高血压大鼠的降压作用。
Br J Pharmacol. 1997 Feb;120(3):399-404. doi: 10.1038/sj.bjp.0700910.
7
[Preparation and biocompatibility of a novel biomimetic osteochondral scaffold: collagen-chitosan/nano-hydroxyapatite-collagen-polylactic acid].新型仿生骨软骨支架:胶原-壳聚糖/纳米羟基磷灰石-胶原-聚乳酸的制备及其生物相容性
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2012 Aug;26(8):1001-6.
8
Chitosan grafted low molecular weight polylactic acid for protein encapsulation and burst effect reduction.壳聚糖接枝低分子量聚乳酸用于蛋白质包封和降低突释效应。
Int J Pharm. 2015 Dec 30;496(2):912-21. doi: 10.1016/j.ijpharm.2015.10.017. Epub 2015 Oct 24.
9
The effect of chitosan on the flammability and thermal stability of polylactic acid/ammonium polyphosphate biocomposites.壳聚糖对聚乳酸/聚磷酸铵生物复合材料的阻燃性和热稳定性的影响。
Carbohydr Polym. 2017 Feb 10;157:1586-1593. doi: 10.1016/j.carbpol.2016.11.035. Epub 2016 Nov 13.
10
Poly(lactic acid)/chitosan hybrid nanoparticles for controlled release of anticancer drug.用于抗癌药物控释的聚乳酸/壳聚糖杂化纳米粒子
Mater Sci Eng C Mater Biol Appl. 2015 Jan;46:514-20. doi: 10.1016/j.msec.2014.10.048. Epub 2014 Oct 23.

引用本文的文献

1
GSH/pH-Responsive Chitosan-PLA Hybrid Nanosystems for Targeted Ledipasvir Delivery to HepG2 Cells: Controlled Release, Improved Selectivity, DNA Interaction, Electrochemical and Stopped-Flow Kinetics Analyses.用于将雷迪帕韦靶向递送至HepG2细胞的谷胱甘肽/ pH响应型壳聚糖-聚乳酸混合纳米系统:控释、选择性提高、DNA相互作用、电化学和停流动力学分析
Int J Mol Sci. 2025 Jun 24;26(13):6070. doi: 10.3390/ijms26136070.
2
Nanoparticle-Based Therapies in Hypertension.基于纳米颗粒的高血压治疗方法。
Hypertension. 2023 Dec;80(12):2506-2514. doi: 10.1161/HYPERTENSIONAHA.123.19523. Epub 2023 Sep 28.
3
Role of Organic and Inorganic Nanoparticles in the Drug Delivery System for Hypertension Treatment: A Systematic Review.
有机和无机纳米颗粒在高血压治疗药物传递系统中的作用:系统评价。
Curr Cardiol Rev. 2022;18(1):e110621194025. doi: 10.2174/1573403X17666210611115823.
4
Potential Strategies to Reduce Blood Pressure in Treatment-Resistant Hypertension Using Food and Drug Administration-Approved Nanodrug Delivery Platforms.利用美国食品药品监督管理局批准的纳米药物递送平台降低顽固性高血压血压的潜在策略。
Hypertension. 2019 Feb;73(2):250-257. doi: 10.1161/HYPERTENSIONAHA.118.12005.